A Study Comparing BL-B01D1 With the Investigator's Choice of Chemotherapy in Patients With Platinum-resistant Recurrent Epithelial Ovarian Cancer(PANKU-GYN01)
Clinical trial NCT06994195 · RECRUITING
Trial details
- NCT number
- NCT06994195
- Sponsor
- Sichuan Baili Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-04
- Primary completion
- 2027-06-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.